Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra 11:39:04 2024-04-26 am EDT After market 03:59:51 pm
27.4 EUR +1.88% Intraday chart for Bayer AG 27.47 +0.27%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bayer CEO wins first AGM shareholder vote RE
BAYER SAYS INVESTORS WITH 91.69% OF EQUITY CAPITAL REPRESENTED A… RE
Dpa-AFX Overview: COMPANIES from 26.04.2024 - 15:15 DP
Bayer: CEO's positive AGM speech welcomed CF
Bayer investor Deka takes a stand against CEO in annual vote RE
Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15 DP
Human rights activists complain to OECD about Bayer over glyphosate DP
German cabinet approves restricted use of herbicide glyphosate RE
Dehoga: Challenging situation for company canteens DP
Germany's Evotec appoints Christian Wojczewski as CEO RE
Global markets live: Bayer, PepsiCo, Halliburton, Spotify, Apple... Our Logo
Bayer: licensing agreement for biological insecticide CF
BAYER AG : Deutsche Bank reiterates its Neutral rating ZD
Bayer, AlphaBio Control Sign Exclusive License Deal for Biological Insecticide MT
European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations MT
JPMorgan rates Bayer at 'Neutral' - Target 34 euros DP
BAYER AG : JP Morgan remains Neutral ZD
Bayer Signs Renewable Energy Purchase Deal for Six German Sites MT
Bayer: signs renewable energy supply contract CF
Capgemini: new platform implemented for Bayer CF
TV ratings: Bayer's Europa League success brings RTL many viewers DP
Bayer’s Investigational Gene Therapy for Heart Failure Gets US FDA Fast Track Designation MT
AskBio receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure CI
Bayer: fast-track procedure in cardiology in the USA CF
Study: US companies outpace Europe and Asia in research spending DP
Chart Bayer AG
More charts
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
26.9 EUR
Average target price
36.9 EUR
Spread / Average Target
+37.22%
Consensus
  1. Stock Market
  2. Equities
  3. BAYN Stock
  4. News Bayer AG
  5. Bayer Donates Over $1 Million To Help Ukraine's Healthcare System